NCT02048163撤回不适用
A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Compare indices of nausea following both prolonged intermittent and short intermittent infusions of meropenem
研究概览
简要总结
The purpose of this study is to compare the incidence of nausea and vomiting following short intermittent versus prolonged intermittent infusion of meropenem.
详细描述
- To assess the number of episodes of emesis following both short and prolonged intermittent infusion of meropenem.
- To assess the number of episodes of emesis corresponding to the peak serum concentration of meropenem.
- To assess the number of episodes of emesis corresponding to the area under the meropenem serum concentration time curve.
- To assess reported nausea, measured through administered dosages of anti-nausea medication, following both short and prolonged intermittent infusion of meropenem.
- To assess reported nausea, measured through administered doses of anti-nausea medication, corresponding to peak concentrations of meropenem.
- To assess reported nausea, measured through administered dosages of anti-nausea medication, corresponding to the area under the serum concentration time curve
- To assess reported nausea, measured through patient-reported nausea measured using pictorial scales of severity of nausea in pediatric patients, following both short and prolonged intermittent infusion of meropenem.
- To assess reported nausea, measured through patient-reported nausea measured using pictorial scales of severity corresponding to the peak serum concentrations of meropenem.
- To assess reported nausea, measured through patient-reported nausea measured using pictorial scales of severity corresponding to the area under the meropenem serum concentration time curve.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 7 Years 至 21 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be an admitted patient at Dayton Children's Hospital.
- •Between 7 and 21 years of age.
- •Have a documented CF diagnosis with one or more of the following clinical features:
- •Sweat chloride > 60 mEq/liter as determined by quantitative pilocarpine iontophoresis test (QPIT).
- •Two mutations (well characterized) in the cystic fibrosis transmembrane conductive regulator (CTFR) gene.
- •Abnormal nasal potential difference.
- •Based on Hankinson/NHanes III criteria, are able to elicit an FEV1 > 25% but with < 95% predicted value when admitted.
- •Sputum or throat swab specimen positive for P. aeruginosa and have a history of at least one additional sputum culture positive for P. aeruginosa within the last 12 months.
- •Are able to perform an acceptable spirometry session (defined as 3 acceptable or usable efforts per ATS/ERS criteria upon admission).
- •Have not smoked tobacco within 28 days prior to Visit 1 and agree not to smoke for the duration of the study.
- •Are able to and have given written informed consent (if they are adults) or assent in combination with consent of their legal representative(s) (if they are minors) in a manner approved by the Institutional Review Board.
- •Patient is experiencing symptoms of CF exacerbation of CF: with any 4 of the following 12 signs or symptoms:
- •Change in sputum;
- •New or increased hemoptysis;
- •Increased cough;
- •Increased dyspnea;
- •Malaise, fatigue or lethargy;
- •Temperature above 38°C;
- •Anorexia or weight loss;
- •Sinus pain or tenderness;
- •Change in sinus discharge;
- •Change in physical examination of the chest;
- •Decrease in pulmonary function by 10 percent or more from a previously recorded value;
- •Radiographic changes indicative of pulmonary infection.
排除标准
- •History of hypersensitivity or intolerance to meropenem.
- •History of hypersensitivity or intolerance to granisetron.
- •Are pregnant, breastfeeding, or unwilling to practice a highly effective method of birth control or abstinence during participation in the study.
结局指标
主要结局
Compare indices of nausea following both prolonged intermittent and short intermittent infusions of meropenem
时间窗: Nausea will be assessed while patient is receiving 4 days of prolonged intermittent infusion and 4 days of short intermittent infusion.
Nausea indices will be measured for each treatment arm by averaging the doses of granisetron requested by each patient, the number of episodes of emesis, and the nausea faces scale scores recorded by patients.
次要结局
- Compare pharmacokinetic data to indices of nausea.(Pharmacokinetic data will be obtained following the third, fourth, or fifth dose of meropenem administered during of each arm of the study. Peak serum concentration and area under the serum concentration time curve will be compared to nausea indices.)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Comparative Study Between Two Routes of Enteral FeedingComplicationNCT04576234Sarah Asmaa60
已完成
不适用
Comparative effects of intermittent versus continuous energy restriction on metabolism following matched weight-lossISRCTN13687043ighterlife UK Ltd27
已完成
不适用
Contraception method IUD,copper IUD and mirenaSequelae of complication of pregnancy, childbirth and the puerperium.Sequelae of complication of pregnancy, childbirth and the puerperiumIRCT138903013881N2Vice chancellor for research of Tehran University of Medical Sciences160
已完成
不适用
Bolus versus continuous studyISRCTN21659064South Tees Hospitals NHS Trust (UK)34
尚未招募
Unknown
A clinical trial conducted on professional cyclists to measure how much oxygen they used while pedaling with restricted blood supply to their upper thighs.CTRI/2023/03/050772Shristi Bharti